Before You Arrive

Before-You-ArriveAt Hope Cancer Care of Nevada, we understand that the anticipation of your first visit can be filled with anxiety. Rest assured, you are about to meet a team of medical professionals dedicated to your recovery. Each team member at Hope Cancer Care of Nevada is 100 percent committed to keeping you informed and at ease during this moment in your life.

Before you arrive, we recommend taking a virtual walkthrough of our facilities in Las Vegas and Pahrump—we believe you’ll like what you’ll see. Take note of the serene atmosphere filled with the luxuries of modern, high-end living. Plush furniture, flat screen TVs, ambient lighting and an overall décor designed to wrap you in comfort. There are also features you can’t see but you will definitely feel them once you arrive, such as our aromatherapy system.

We invite you to bring a list of any questions you may have. Our friendly staff and your personal oncologist are here to answer them before, during and long after your graduation. If you are still feeling a bit hesitant, get to know the Hope Cancer Care of Nevada team by viewing their “bios”. You’ll find that they are highly trained and highly personable individuals who can’t wait to welcome you into our family.

At Hope Cancer Care of Nevada, our patients are just that—family. As you progress through your current journey, we want you to know that you are not alone. Graduates of the Hope cancer treatment program are our biggest advocates, and are eager to share their personal insights, experiences and thoughts regarding their time at Hope Cancer Care of Nevada. Listen to what they have to say by reading their testimonials.

We look forward to personally getting to know you while assisting you in achieving a steady recovery at Hope Cancer Care of Nevada.

slide_0

NCI-COG Pediatric MATCH trial to test targeted drugs in childhood cancers

07/24/17

The nationwide precision medicine trial will enroll children and adolescents with advanced cancers that haven’t responded to standard therapy to explore treatments targeted at specific genetic mutations. …read more Source:: Cancer


TCGA study of liver cancer reveals potential targets for therapy

06/15/17

Only two drugs are FDA-approved for liver cancer. This study of hepatocellular carcinoma found genetic alterations in tumors—including mutations in tumor-suppressing genes and high expression of immune checkpoint genes—that could be targets for drugs that already exist. …read more Source:: … Read More


Don’t Fry Day: Getting Sunscreen Right

05/25/17

By David Sampson Despite increased awareness about the dangers of ultraviolet (UV) radiation, melanoma rates continue to rise in the United States. For “Don’t Fry Day” on May 26, the American Cancer Society is cautioning that many people may be … Read More


Ventilated Filters: Changing the Face of Lung Cancer in the U.S.

05/23/17

By David Sampson An analysis appearing in the Journal of the National Cancer Institute finds strong evidence that adding ventilation holes to cigarette filters has contributed to a rise in a type of lung cancer called adenocarcinoma among smokers. The … Read More


Study estimates number of U.S. women living with metastatic breast cancer

05/18/17

A new study shows that the number of women in the United States living with distant metastatic breast cancer (MBC), the most severe form of the disease, is growing. This is likely due to the aging of the U.S. population … Read More


14: The Unmentioned Number in the Prostate Cancer/Coffee Story

05/05/17

By David Sampson Headlines across the Internet blared with the news over the past week that coffee could cut the risk of prostate cancer in half. It was an irresistible headline. But just how reliable was the finding? What if … Read More


Panel Re-Opens the Door for PSA Screening in Men 55-69

04/11/17

By David Sampson The U.S. Preventive Services Task Force (USPSTF) has released draft recommendations for the use of prostate-specific antigen (PSA) screening for prostate cancer. The recommendation, which awaits public comment before being finalized, says the decision about whether to … Read More


Annual Report to the Nation: Cancer death rates continue to decline

03/31/17

According to the latest Annual Report to the Nation on the Status of Cancer, 1975-2014, overall cancer death rates continue to decrease in men, women, and children for all major racial and ethnic groups. But more work remains for some … Read More


The ‘Bad Luck’ Cancer Analysis, Part II

03/25/17

By David Sampson A new study revisits an analysis made by the same lab in 2015 about the role of random mutations on cancer. The analysis uses computer modeling to estimate how many cancers are the result of replication errors. … Read More


ACS Study: Finds Colorectal Cancer Rates Have Risen Dramatically in Gen X and Millennials

02/28/17

By David Sampson A groundbreaking study by American Cancer Society epidemiologist Rebecca Siegel, MPH finds that people born in the United States in 1990 have double the risk of colon cancer and quadruple the risk of rectal cancer compared to … Read More